Custom made core-multishell nanocarriers

DendroPharm´s advanced DendroSol® technology significantly improves drug solubility and skin penetration. Our nanocarriers offer selective targeting of tumors and inflamed tissue. Please contact us for your custom made nanocarrier synthesis.

Diffusion cell tests for dermal delivery & tests for active compound release

DendroPharm offers the following services:
         - Artificial skin model
         - Nude mouse/nude rat model
         - Human skin model
         - Drug release studies
         - Development of HPLC methods

Formulation & drug development

Profit from our drug development experience. We coordinate all required steps from discovery towards a functioning and validated GMP production of your drug.

Regulatory affairs, project management & dossier writing

We manage your drug development project with up to date drug regulatory expertise. We pepare your meetings with regulatory agencies and support you in all necessary steps for a sucessful dossier (all CTD Modules). In addition we manage your nonclinical and clinical study program.

Please contact us for more details.

DendroPharm is interested in collaborations with companies or academic research groups to develop new drugs and novel drug delivery systems.

DendroPharm GmbH, in collaboration with the University Medical Center of the Charité and Freie Universität Berlin, develops non-sedative, non-addictive painkillers in the "NanoOpiat" project. This project is funded by the European Union within the framework of EFRE funding.

DendroPharm is a member of the "Network for Pharma Solutions" NetPhaSol.

DendroPharm Company Videos

DendroPharm: Innovation in veterinary medicine

Brief TV report on DendroPharm

Business Model Canvas - Dendropharm

News

October 2017 | DendroPharm becomes member of the "Network for Pharma Solutions" (NetPhaSol, Germany). This cooperation network for drug development serves as a platform for research, development and marketing of new products, processes and services.

Dezember 2016 | DendroPharm wins the Innovation Award Berlin-Brandenburg.

September 2015 | TÜV-SÜD certifies the quality management system of DendroPharm according to ISO 9001:2008.

December 2014 | DendroPharm qualifies for inclusion in the BAFA program for a 20% subsidy for direct private investments from 10.000 €. If interested, please get in touch with the management.


Read more